Nanoviricides NNVC
NYSE NNVC
$1.51 +0.21 (+16.15%)
As of: Oct 20, 2026 · 3:58 PM EDT

Nanoviricides (NNVC) Accounts Payables (2011 - 2026)

Updated

Nanoviricides (NNVC) posted Accounts Payables of $2.31 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 80.0% from $1.28 million a year earlier and up 10.9% from the prior quarter.

Analysis

Nanoviricides (NNVC) Accounts Payables (2011 - 2026) Analysis & Trends

Since fiscal Q4 2011, Nanoviricides has reported Accounts Payables for 61 quarters.

  • Annual Accounts Payables has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 63.1% (FY2021 to FY2026).
  • In prior fiscal years, Nanoviricides' Accounts Payables was $1.28 million in FY2025 (+16.8%), $1.1 million in FY2024 (+49.5%), $733,434 in FY2023 and $57,960 in FY2022 (-71.0%).
  • Quarterly Accounts Payables has run from a low of $37,690 in fiscal Q1 2023 to a high of $2.31 million in fiscal Q1 2026 over five years.
  • On a year-over-year basis, Accounts Payables has increased in each of the last ten quarters, with growth averaging 91.9% over the last eight quarters.
  • The strongest year-over-year quarter for Accounts Payables in the past five years was fiscal Q3 2024, with growth of 444.5%; the weakest was fiscal Q2 2023, with a decline of 74.3%.
  • According to Business Quant data, Accounts Payables for the three prior fiscal quarters was $2.08 million (Q3 2026), $2.29 million (Q2 2026) and $2.31 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 9.22 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 33.30 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 3.83 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 22.89 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 674.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 4.58 Bn
10 Nanoviricides 30.08 Mn 17.74 Mn - 2.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.31 Mn
Mar 31, 2026 2.08 Mn
Dec 31, 2025 2.29 Mn
Sep 30, 2025 2.31 Mn
Jun 30, 2025 1.28 Mn
Mar 31, 2025 1.17 Mn
Dec 31, 2024 2.24 Mn
Sep 30, 2024 2.06 Mn
Jun 30, 2024 1.10 Mn
Mar 31, 2024 341,394.00
Dec 31, 2023 831,227.00
Sep 30, 2023 879,485.00
Jun 30, 2023 733,434.00
Mar 31, 2023 62,695.00
Dec 31, 2022 39,291.00
Sep 30, 2022 37,690.00
Jun 30, 2022 57,960.00
Mar 31, 2022 122,987.00
Dec 31, 2021 153,180.00
Sep 30, 2021 116,248.00
API Access

Nanoviricides Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=NNVC&period=max&api_key=YOUR_API_KEY